BNYMC Modifies Stake in Immutep Limited
Company Announcements

BNYMC Modifies Stake in Immutep Limited

Immutep Ltd (AU:IMM) has released an update.

Immutep Limited has experienced a shift in its substantial holding structure, with The Bank of New York Mellon Corporation (BNYMC) reporting a change in voting power from 20.44% to 16.60% as of June 12, 2024. This adjustment reflects a shift in the interests of the substantial holder since their last notice to the company. The details of the changes in relevant interests and associations are outlined, signifying a repositioning within Immutep’s investor base.

For further insights into AU:IMM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskImmutep Ltd Updates on Immune-Oncology Progress
TipRanks Australian Auto-Generated NewsdeskImmutep’s Head & Neck Cancer Therapy Excels
TheFlyImmutep announces first participant dosed in Phase I study of IMP761
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!